stella
beta
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer — Stella
Recruiting
Back to IBI363 + Chemotherapy trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
View full record on ClinicalTrials.gov